SINOVAC BIOTECH LTD (SVA) › Operating Cash FlowSINOVAC BIOTECH LTD (SVA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2013: $5.58M2014: -$10.13M2015: $4.21M2016: -$13.90M2017: $59.76M2018: $7.94M2019: $39.07M2020: $479.31M2021: $15.32B2022: -$798.12M2023: $138.65M2024: -$56.89M2025: -$512.18M-$512.18M2013Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$512.18M-800.3%2024-$56.89M-141.0%2023$138.65M+117.4%2022-$798.12M-105.2%2021$15.32B+3096.7%2020$479.31M+1126.7%2019$39.07M+391.9%2018$7.94M-86.7%2017$59.76M+529.8%2016-$13.90M-430.1%2015$4.21M+141.6%2014-$10.13M-281.6%2013$5.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share